HRP920949A2 - Method and device for injection - Google Patents

Method and device for injection Download PDF

Info

Publication number
HRP920949A2
HRP920949A2 HR920949A HRP920949A HRP920949A2 HR P920949 A2 HRP920949 A2 HR P920949A2 HR 920949 A HR920949 A HR 920949A HR P920949 A HRP920949 A HR P920949A HR P920949 A2 HRP920949 A2 HR P920949A2
Authority
HR
Croatia
Prior art keywords
movable wall
container
solution
injection
holder
Prior art date
Application number
HR920949A
Other languages
Croatian (hr)
Inventor
Birger Hjertman
Anders Strom
Ebba Florin-Robertsson
Bo Ahlstrand
Linda Fryklund
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE8702735A external-priority patent/SE465065B/en
Priority claimed from SE8801405A external-priority patent/SE464797B/en
Priority claimed from YU128488A external-priority patent/YU46917B/en
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Publication of HRP920949A2 publication Critical patent/HRP920949A2/en
Publication of HRP920949B1 publication Critical patent/HRP920949B1/en

Links

Landscapes

  • Diaphragms For Electromechanical Transducers (AREA)
  • Injection Moulding Of Plastics Or The Like (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Description

Područje tehnike u koju spada izum The technical field to which the invention belongs

Izum spada u područje uređaja za unošenje agenasa u tijelo, a posebno se odnosi na brizgalice za injekcije. Oznaka prema Međunarodnoj klasifikaciji patenata: A 61 M 5/24. The invention belongs to the field of devices for introducing agents into the body, and especially relates to syringes for injections. Designation according to the International Classification of Patents: A 61 M 5/24.

Tehnički problem Technical problem

Izumom se rješava problem kako konstrukcijski izvesti uređaj za ubrizgavanje injekcija koji će omogućiti nošenje ampula sa dvokomponentnim medikamentima i miješanje tih, obično osjetljivih komponenata kod ubrizgavanja. The invention solves the problem of how to design a device for injecting injections that will allow carrying ampoules with two-component medications and mixing these, usually sensitive, components during injection.

Stanje tehnike State of the art

Ovaj se izum odnosi na uređaje za ubrizgavanje injekcija, posebno za upotrebu u ambulantnom liječenju. Točnije, izum se odnosi na uređaj pomoću kojeg se otopina za ubrizgavanje neke materije, supstancije, priprema neposredno prije ubrizgavanja, ili se priprema nekoliko doza prije prve injekcije. This invention relates to devices for injecting injections, particularly for use in ambulatory treatment. More specifically, the invention relates to a device by which a solution for injecting a substance is prepared immediately before injection, or several doses are prepared before the first injection.

Uređaji za ubrizgavanje injekcija u ambulantnom liječenju gdje se medikament nalazi u otopini, poznati su od ranije i široko su korišteni, na primjer, kod liječenja šećerne bolesti inzulinom. Takvi uređaji su obično načinjeni tako da sam pacijent može sklopiti lako jednu cilindričnu ampulu za jednu ili više doza, jednu iglu za injekcije i napravu za doziranje u jednom pogodnom držaču, poslije čega može sebi lako dati potrebnu injekciju. Kod tog uređaja se lako mogu zamijeniti ampule i igle novim. U sklopljenom stanju su takvi uređaji za ubrizgavanje često oblikovani kao nalivpero i pacijent ih može lako nositi sa sobom. Devices for injecting injections in ambulatory treatment where the medication is in solution have been known for a long time and have been widely used, for example, in the treatment of diabetes with insulin. Such devices are usually made so that the patient himself can easily assemble one cylindrical ampoule for one or more doses, one injection needle and a dosing device in one convenient holder, after which he can easily give himself the necessary injection. With this device, ampoules and needles can be easily replaced with new ones. When folded, such injection devices are often shaped like a fountain pen and can be easily carried by the patient.

Pored toga, poznati su tzv. dvokomorni ili posude za miješanje ili cilindrične ampule za pripremanje otopina osjetljivih supstancija neposredno prije ubrizgavanja. Takve posude su podijeljene na dvije komore razdvojene jednim pomičnim zidom ili klipom. Osjetljivi medikament se nalazi u prednjoj komori u suhom, obično zamrzavanjem osušenom stanju, a prednji kraj prednje komore je zatisno zatvoren jednim zidom koji može probiti igla za injekcije. Tekućina koja treba otopiti osjetljivu supstanciju prije ubrizgavanja nalazi se u stražnjoj komori. Dvije komore su razdvojene prednjim pomičnim zidom, a zadnji kraj stražnje komore je zatisno zatvoren pomoću stražnjeg pomičnog zida. Pored toga, u zidu posude je izveden spojni kanal koji može povezati prednju i stražnju komoru. In addition, the so-called two-chamber or mixing vessels or cylindrical ampoules for preparing solutions of sensitive substances immediately before injection. Such containers are divided into two chambers separated by a movable wall or piston. The sensitive medicament is contained in the anterior chamber in a dry, usually freeze-dried state, and the anterior end of the anterior chamber is sealed by a single wall that can be penetrated by an injection needle. The liquid that needs to dissolve the sensitive substance before injection is in the back chamber. The two chambers are separated by a front movable wall, and the rear end of the rear chamber is sealed by means of a rear movable wall. In addition, there is a connecting channel in the vessel wall that can connect the front and back chambers.

U položaju uskladištenja prije ubrizgavanja, nema veze između prednje i stražnje komore. Ulaz, kao i izlaz spojnog kanala završava se u prednjoj komori. In the pre-injection storage position, there is no connection between the anterior and posterior chambers. The entrance, as well as the exit of the connecting channel, ends in the anterior chamber.

Kada se kontejner treba pripremiti za ubrizgavanje, stražnji pomični zid u stražnjoj komori pomiče se prema naprijed, a zbog nestišljivosti tekućine, i prednji pomični zid će se pomicati u naprijed dok ne dostigne položaj nasuprot spojnog kanala u zidu kontejnera. Kada se poslije toga stražnji pomični zid pomiče i dalje u naprijed, tekućina će biti potisnuta kroz preljevni kanal u prednju komoru gdje će doći u dodir s medikamentom i isti otopiti. Kod ubrizgavanja će ta dva zida djelovati zajedno kao jedan klip i istisnuti pripremljenu otopinu za ubrizgavanje kroz jednu iglu koja je umetnuta kroz prednji krajnji zid u prednjoj komori. When the container is to be prepared for injection, the rear movable wall in the rear chamber moves forward, and due to the incompressibility of the liquid, the front movable wall will also move forward until it reaches a position opposite the connecting channel in the container wall. When the rear movable wall moves further forward after that, the liquid will be pushed through the overflow channel into the front chamber where it will come into contact with the medication and dissolve it. When injected, these two walls will act together as a single piston and force the prepared injection solution through a single needle inserted through the anterior end wall in the anterior chamber.

U nekim slučajevima medikament može biti toliko osjetljiv, da se moraju poduzimati posebne mjere da se supstancija zaštiti od mehaničkih utjecaja u trenutku otapanja kao i pri daljnjem rukovanju otopinom. To vrijedi, na primjer, na zamrzavanjem sušene hormone rasta gdje čak i jednostavna trešnja supstancije i tekućine može dovesti do neprihvatljivih biokemijskih promjena. Zbog toga priprema kontejnera za ubrizgavanje mora se izvesti s najvećom mogućom pažnjom. In some cases, the medication can be so sensitive that special measures must be taken to protect the substance from mechanical influences at the time of dissolution as well as during further handling of the solution. This applies, for example, to freeze-dried growth hormones where even a simple mixing of the substance and liquid can lead to unacceptable biochemical changes. Therefore, the preparation of the injection container must be carried out with the greatest possible care.

Bilo bi vrlo poželjno imati na raspolaganju uređaj za ubrizgavanje injekcija koji se može lako nositi i primjenjivati kao do sada poznate jednostavne cilindrične ampule, u kojima se medikament nalazi u tekućem stanju kao otopina, suspenzija ili emulzija, a koji će istodobno moći koristiti prednosti kontejnera za miješanje kod ubrizgavanja osjetljivih supstancija. It would be highly desirable to have available a device for injecting injections that can be easily carried and applied like the simple cylindrical ampoules known so far, in which the medication is in a liquid state as a solution, suspension or emulsion, and which at the same time will be able to use the advantages of containers for mixing when injecting sensitive substances.

Opis rješenja tehničkog problema Description of the solution to the technical problem

Prema izumu ostvaren je uređaj za pripremu otopine za ubrizgavanje jedne ili više supstancija osjetljivih na opadanje svojstava, i za ubrizgavanje te otopine. According to the invention, a device was created for preparing a solution for injecting one or more substances sensitive to the deterioration of properties, and for injecting this solution.

Cilj je uređaja prema izumu da se njime pripremi otopina, emulzija ili suspenzija u vodi jednog ili više osjetljivih medikamenata za jedno ili više uzastopnih ubrizgavanja, korištenjem jedne poznate višekomorne cilindrične ampule, koja je zatisno zatvorena na svom prednjem kraju jednom membranom koju može probiti igla za injekcije, a ograničen je sa stražnje strane prednjim pomičnim zidom, zatim stražnji prostor koji sadrži jednu vodenu fazu, a koji je na prednjem kraju ograničen prednjim pomičnim zidom, i ograničen je sa stražnje strane stražnjim pomičnim zidom, kao i jedan spojni kanal izveden u zidu ampule između stražnjeg i prednjeg prostora, pri čemu se stražnji pomični zid pomiče prema naprijed i pokreće vodenu fazu i prednji pomični zid, sve dok ne dospije nasuprot preljevnog kanala, tako da tekuća faza pri daljnjem kretanju u naprijed stražnjeg pomičnog zida teče pored prednjeg pomičnog zida u prednji prostor i otapa, emulgira ili suspendira medikament. Ono što je karakteristično za uređaj je to, što vodena faza teče mirno odozgo naviše kroz medikament pri čemu se izbjegava trešnja i miješanje zraka. The aim of the device according to the invention is to prepare a solution, emulsion or suspension in water of one or more sensitive drugs for one or more consecutive injections, using a known multi-chamber cylindrical ampoule, which is sealed at its front end with a membrane that can be pierced by a needle for injections, and is limited from the rear by the front movable wall, then the rear space containing one water phase, which is limited at the front end by the front movable wall, and is limited from the rear by the rear movable wall, as well as a connecting channel made in the wall ampoule between the rear and front spaces, wherein the rear movable wall moves forward and drives the aqueous phase and the front movable wall, until it reaches opposite the overflow channel, so that the liquid phase on further forward movement of the rear movable wall flows past the front movable wall into the anterior space and dissolves, emulsifies or suspends the medication. What is characteristic of the device is that the water phase flows calmly from above through the medicine, avoiding cherry and air mixing.

Za uređaj prema izumu karakteristično je to što obuhvaća: The device according to the invention is characterized by the fact that it includes:

a) kontejner za sastavne elemente otopine za ubrizgavanje, u kome se te komponente drže razdvojene, ali se mogu miješati djelovanjem izvana da bi se miješali i otopili, a koje je izvedeno u obliku cijevi koja je zatisno zatvorena na svom prednjem dijelu pomoću jedne membrane koja se može probiti, pri čemu se u jednom prostoru između zida koji se može probiti i jednog prednjeg pomičnog zida drže krute komponente otopine za ubrizgavanje, a u prostoru između prednjeg pomičnog zida i jednog stražnjeg pomičnog zida drže se tekuće komponente otopine za ubrizgavanje, dok je u cjevastom zidu izveden jedan spojni kanal, postavljen tako da, kada se stražnji pomični zid pomakne u naprijed zajedno s tekućinom i prednjim pomičnim zidom, tekućina može teći pored prednjeg pomičnog zida i miješa se sa krutim komponentama i oblikuje otopinu; a) a container for the components of the solution for injection, in which these components are kept separate, but can be mixed by external action to mix and dissolve, which is made in the form of a tube that is hermetically sealed at its front by means of a single membrane that is penetrable, wherein a space between the penetrable wall and one front movable wall holds the solid components of the injection solution, and the space between the front movable wall and one rear movable wall holds the liquid components of the injection solution, while in a connecting channel formed in the tubular wall, placed in such a way that, when the rear movable wall is moved forward together with the liquid and the front movable wall, the liquid can flow past the front movable wall and mix with the solid components and form a solution;

b) držač u koji se može učvrstiti kontejner tako da se komponente otopine za ubrizgavanje dovedu u dodir i pomiješaju, a koji je načinjen od dva cjevasta elementa koji se mogu spojiti navojem i obuhvatiti kontejner, tako da kada se ovi elementi spoje navojem, prednji kraj kontejnera je s membranom koja se može probiti izložen kod prednjeg kraja držača da bi bio probijen iglom za injekcije, pri čemu se stražnji pomični zid kod stražnjeg dijela kontejnera pomiče u naprijed zajedno s tekućinom i sa prednjim pomičnim zidom tako da je tekućina primorana teći kroz spojni kanal u prostor krutih komponenata, da bi se sa istima miješala i oblikovala otopinu; b) a holder in which the container can be fixed so that the components of the solution for injection are brought into contact and mixed, which is made of two tubular elements that can be threadedly connected and encompass the container, so that when these elements are threadedly connected, the front end container with a penetrable membrane is exposed at the front end of the holder to be pierced by the injection needle, the rear movable wall at the rear of the container is moved forward with the liquid and with the front movable wall so that the liquid is forced to flow through the coupling a channel into the space of solid components, in order to mix with them and form a solution;

c) držač igle za injekcije koja je prilagođena da se postavi na prednji dio držača kontejnera, tako da se igla može spojiti sa unutrašnjošću kontejnera kroz membranu koja se može probiti, i c) an injection needle holder which is adapted to be placed on the front of the container holder so that the needle can be connected to the interior of the container through a penetrable membrane, and

d) naprava za doziranje povezana s držačem kontejnera, čijim se djelovanjem stražnji pomični zid u kontejneru pomiče u naprijed ispuštajući pri tome određene doze otopine za ubrizgavanje, pri čemu se naprava za doziranje dovodi u početni položaj za doziranje kada su dijelovi držača kontejnera spojeni navojem. d) a dosing device connected to the container holder, by the action of which the rear movable wall in the container moves forward, thereby releasing certain doses of the solution for injection, whereby the dosing device is brought to the initial dosing position when the parts of the container holder are threaded.

Izum također obuhvaća jednu univerzalnije upotrebljivu napravu za pripremanje otopina za ubrizgavanje od komoponenata postavljenih u kontejner prema točki a) naprijed. The invention also includes a more universally usable device for preparing injection solutions from the components placed in the container according to point a) above.

U sljedećem tekstu izum je detaljnije opisan s pozivom na priložene crteže. In the following text, the invention is described in more detail with reference to the attached drawings.

Jedno izvođenje uređaja prema izumu prikazano je na crtežima. One embodiment of the device according to the invention is shown in the drawings.

Slika 1 nacrta prikazuje dvokomornu cilindričnu ampulu koja ima dvije komore za primjenu u uređaju za ubrizgavanje. Figure 1 of the drawing shows a two-chamber cylindrical ampoule having two chambers for use in an injection device.

Slika 2 predstavlja opći izgled uređaja za ubrizgavanje prema izumu. Figure 2 presents a general view of the injection device according to the invention.

Slika 3 prikazuje isti uređaj u rastavljenom stanju. Figure 3 shows the same device in a disassembled state.

Slika 4 je presjek uređaja u rastavljenom stanju. Figure 4 is a cross-section of the device in a disassembled state.

Slika 5 prikazuje uređaj spreman za ubrizgavanje. Figure 5 shows the device ready for injection.

Slika 6 prikazuje, shematski, izgled prve varijante izvođenja uređaja prema izumu u položaju prije pripremanja otopine za ubrizgavanje. Figure 6 shows, schematically, the appearance of the first embodiment of the device according to the invention in the position before preparing the injection solution.

Slika 7 prikazuje, shematski, izgled uređaja sa slike 6 nakon pripreme otopine za ubrizgavanje. Figure 7 shows, schematically, the appearance of the device from Figure 6 after preparation of the injection solution.

Slika 8 predstavlja, shematski, izgled uređaja prikazanog na slikama 6 i 7 pri unošenju pripremljene otopine u iglu za injekcije. Figure 8 represents, schematically, the appearance of the device shown in Figures 6 and 7 when introducing the prepared solution into the injection needle.

Slika 9 prikazuje, shematski, izgled druge varijante izvođenja izuma u položaju prije priprema otopine za ubrizgavanje. Figure 9 shows, schematically, the appearance of the second embodiment of the invention in the position before preparing the solution for injection.

Slika 10 prikazuje, shematski, izgled uređaja sa slike 9 nakon pripreme otopine za ubrizgavanje. Figure 10 shows, schematically, the appearance of the device from Figure 9 after preparation of the injection solution.

Slika 11 prikazuje, shematski, izgled uređaja prema slikama 9 i 10 s postavljenom cjevčicom, kanulom, pripremljen za ubrizgavanje. Fig. 11 shows, schematically, the appearance of the device according to Figs. 9 and 10 with the inserted tube, cannula, prepared for injection.

Presjek dvokomorne cilindrične ampule koja se koristi u uređaju za ubrizgavanje prema izumu prikazan je na slici 1. Ampula se sastoji od cijevi 1, preporučljivo od stakla ili plastične mase, koja je izvedena sa grlom s prirubnicom 2 na njegovom prednjem dijelu. Prednji dio je zatisno zatvoren membranom 3 načinjenom od gume ili pogodnog plastičnog materijala, koja je pričvršćena metalnom kapsulom 4. Kapsula 4 ima otvor 5 u svom srednjem dijelu, tako da je tu membrana 3 nepokrivena. Rubni dio kapsule je povijen oko prirubnice 2, tako da je membrana 3 pričvršćena na prednjem otvoru ampule. A section of the two-chamber cylindrical ampoule used in the injection device according to the invention is shown in Figure 1. The ampoule consists of a tube 1, preferably made of glass or plastic, which is made with a neck with a flange 2 on its front part. The front part is sealed with a membrane 3 made of rubber or a suitable plastic material, which is attached by a metal capsule 4. The capsule 4 has an opening 5 in its middle part, so that there the membrane 3 is uncovered. The edge part of the capsule is bent around the flange 2, so that the membrane 3 is attached to the front opening of the ampoule.

Ampula je podijeljena na prednji prostor 6 i na stražnji prostor 7 pomoću pomične pregrade 8. Stražnji kraj ampule je zatisno zatvoren pomičnim zidom 9 koji, pri tome, također zatisno zatvara stražnju komoru 7. Dva pomična zida 8 i 9 mogu se pomicati u naprijed u ampuli osiguravajući zatiskivanje uz zid ampule, pri čemu ova ampula u tom cilju ima kružno cilindrični oblik. The ampoule is divided into a front space 6 and a back space 7 by means of a movable partition 8. The rear end of the ampoule is sealingly closed by a movable wall 9, which, at the same time, also seals the rear chamber 7. The two movable walls 8 and 9 can be moved forward in ampoule ensuring sealing against the wall of the ampoule, whereby this ampoule has a circular cylindrical shape for this purpose.

Prednja komora 6 ampule sadrži jedan ili više medikamenata 10 u suhom stanju, preporučljivo osušenih zamrzavanjem. U tom obliku i osjetljive supstancije imaju relativno dobru stabilnost. Stražnja komora 7 sadrži tekuću fazu 11 koja je namijenjena za otapanje suhe supstancije za ubrizgavanje. Ova tekuća faza obično se sastoji od vode ili fiziološke slane otopine, i takvih dodatnih supstancija koje su uobičajene u farmakološkoj praksi i mogu se dodati otopini. The front chamber 6 of the ampoule contains one or more medications 10 in a dry state, preferably freeze-dried. In this form, even sensitive substances have relatively good stability. The rear chamber 7 contains the liquid phase 11, which is intended for dissolving the dry substance for injection. This liquid phase usually consists of water or physiological saline, and such additional substances as are common in pharmacological practice and may be added to the solution.

U zidu ampule je izveden spojni kanal, u obliku jednog udubljenja koji je postavljen i pruža se u uzdužnom pravcu ampule. Preljevni kanal 12 je postavljen tako da je potpuno u prednjem prostoru 6 prije nego što je ampula pripremljena za ubrizgavanje, a dužina mu je takva da omogućava protok pored pomičnog zida 8. In the wall of the ampoule there is a connecting channel, in the form of a depression that is placed and extends in the longitudinal direction of the ampoule. The overflow channel 12 is placed so that it is completely in the front space 6 before the ampoule is prepared for injection, and its length is such that it allows flow past the movable wall 8.

Na slici 2 prikazan je uređaj za ubrizgavanje prema izumu u sklopljenom stanju tako da ga pacijent može lako nositi sa sobom. Uređaj je obično oblikovan kao nalivpero i sastoji se od prednjeg kućišta 13 koje obuhvaća jednu dvokomornu cilindričnu ampulu prema slici 1 za agens koji će se ubrizgati, stražnje kućište 14 koje obuhvaća jedan mehanizam za doziranje i primjenu agenasa, i jednu zaštitnu kapu 15 preko igle za ubrizgavanje. Mehanizam za doziranje i primjenu agensa načinjen je na jedan od poznatih načina i ovdje neće biti detaljnije opisivan. Obično djeluje na takav način da se upravljačko dugme 16 na stražnjem dijelu uređaja okrene tako da se jedan indeks postavi nasuprot jedne skale čime se određuje jedna pogodna doza. Kod primjene lijekova, upravljačko dugme se pritisne čime se jedna određena doza ispušta kroz iglu. Mnoga različita izvođenja takvog jednog mehanizma za doziranje i davanje lijekova poznata su od ranije i mogu se koristiti u uređajima za ubrizgavanje prikazanog izuma. Figure 2 shows the injection device according to the invention in a folded state so that the patient can easily carry it with him. The device is usually shaped like a fountain pen and consists of a front housing 13 that includes a two-chamber cylindrical ampoule according to Figure 1 for the agent to be injected, a rear housing 14 that includes a mechanism for dosing and applying the agents, and a protective cap 15 over the needle for injection. The mechanism for dosing and applying the agent is made in one of the known ways and will not be described in detail here. It usually works in such a way that the control knob 16 on the back of the device is turned so that one index is placed against one scale which determines one suitable dose. When administering drugs, the control button is pressed, which releases a certain dose through the needle. Many different embodiments of such a single drug dosing and delivery mechanism are known in the past and can be used in the injection devices of the present invention.

Na slici 3 je prikazan uređaj za ubrizgavanje u rastavljenom stanju. Ovdje je skinuta i zaštitna kapa 15 tako da je prikazan prednji dio 17 igle s njenim držačem 18. Igla se može navrnuti na prednji dio prednjeg kućišta 13 pomoću držača i može se lako zamijeniti. Nakon toga se zaštitna kapa 15 mora držati postavljena cijelo vrijeme kako bi se održala sterilnost i ne treba se uklanjati sve do neposredno prije ubrizgavanja. Na prednjem kućištu 13 načinjen je otvor 19 kroz koji korisnik može lako provjeriti da li je neka ampula umetnuta i koliko je još preostalo otopine za ubrizgavanje. Figure 3 shows the injection device in a disassembled state. Here the protective cap 15 has been removed so that the front part 17 of the needle with its holder 18 is shown. The needle can be screwed onto the front part of the front housing 13 by means of the holder and can be easily replaced. Thereafter, the protective cap 15 must be kept in place at all times to maintain sterility and should not be removed until just before injection. An opening 19 is made on the front case 13 through which the user can easily check whether an ampoule has been inserted and how much injection solution is left.

Stražnje kućište 14 može se zavrnuti u prednje kućište 13 pomoću navoja 20. Istodobno s ovim uvrtanjem, umetnuta dvokomorna cilindrična ampula za ubrizgavanje se priprema, što će biti detaljnije opisano u sljedećem tekstu. The back housing 14 can be screwed into the front housing 13 by means of the thread 20. Simultaneously with this screwing, the inserted two-chambered cylindrical ampoule for injection is prepared, which will be described in more detail in the following text.

Slika 4 predstavlja izgled, djelomično u uzdužnom presjeku, rastavljenog uređaja za ubrizgavanje prema slici 3. Ovdje je očigledno da je dvokomorna cilindrična kapsula tipa prikazanog na slici 1 umetnuta u prednje kućište 13 i pomična toliko naprijed, da je njena membrana 3 otkrivena kako bi je probušila igla. U stražnjem kućištu 14 je mehanizam za doziranje i ispuštanje shematski prikazan i označen sa 22. Taj mehanizam ima prema naprijed usmjerenu radnu šipku 23. Aktiviranjem iste, dvokomoponentna cilindrična ampula je prva pripremljena za ubrizgavanje, pa se nakon toga određene doze agensa za ubrizgavanje mogu raspodijeliti pomoću upravljačkog dugmeta 16. Fig. 4 represents a view, partly in longitudinal section, of the disassembled injection device of Fig. 3. Here it is evident that a two-chambered cylindrical capsule of the type shown in Fig. 1 is inserted into the front housing 13 and moved so far forward that its membrane 3 is exposed in order to punctured by a needle. In the rear housing 14, the dosing and dispensing mechanism is shown schematically and marked 22. This mechanism has a forward-directed operating rod 23. By activating it, the two-component cylindrical ampoule is first prepared for injection, after which certain doses of the injection agent can be dispensed using control button 16.

Stražnje kućište 14 može se zavrnuti u prednje kućište 13 pomoću vanjskog navoja 20 koji se spreže sa unutarnjim navojem 24. The rear housing 14 can be screwed into the front housing 13 by means of an external thread 20 that engages with an internal thread 24.

Slika 5 prikazuje uređaj sklopljen i spreman za ubrizgavanje. Ovdje je stražnji pomični zid 9 toliko pomaknut da je došao u dodir s prednjim pomičnim zidom 8. Ovaj je pomaknut toliko da je došao nasuprot spojnog kanala 12 i tekuća je faza protjecala pored prednjeg pomičnog zida 8 i miješala sa sa suhim medikamentom. Zašiljeni stražnji dio 21 igle takoder je probio kroz membranu 3. Dva pomična zida 8 i 9 u medusobnom su dodiru pomaknuti toliko da je sav zrak iz prednjeg prostora 6 istisnut kroz iglu. Uređaj je spreman za ubrizgavanje. Figure 5 shows the device assembled and ready for injection. Here, the rear movable wall 9 is moved so much that it comes into contact with the front movable wall 8. The latter is moved so much that it comes opposite the connecting channel 12 and the liquid phase flows past the front movable wall 8 and mixes with the dry medicament. The pointed back part 21 of the needle also broke through the membrane 3. The two movable walls 8 and 9 in mutual contact were moved so much that all the air from the front space 6 was forced out through the needle. The device is ready for injection.

Funkcioniranje uređaja nakon što je pripremljen za ubrizgavanje je sljedeće: The operation of the device after it is prepared for injection is as follows:

U stražnjem kućištu 14 radna šipka 23 i kontrolno dugme 16 mehanizma 22 za doziranje i raspodjelu postave se prvo na početni ili nulti položaj. To se čini na način koji je određen konstrukcijom mehanizma koji je inače poznat. Potom se stražnje kućište 14 zavrće u prednje kućište 13 sve dok se radna šipka 23 ne osloni ovlaš na stražnji pomični zid 9 u dvokomornoj cilindričnoj ampuli. In the rear case 14, the operating rod 23 and the control button 16 of the mechanism 22 for dosing and distribution are first placed in the initial or zero position. This is done in a manner determined by the construction of the mechanism, which is otherwise known. Then, the back housing 14 is screwed into the front housing 13 until the working rod 23 rests completely on the rear movable wall 9 in the two-chamber cylindrical ampoule.

Ako se stražnje kućište i dalje zavrće, radna poluga će potisnuti stražnji pomični zid 9 prema naprijed u cilindričnoj ampuli, a kako je tekućina 11 u stražnjem prostoru 7 u biti If the back housing continues to screw, the operating lever will push the back movable wall 9 forward in the cylindrical ampoule, and as the liquid 11 in the back space 7 is essentially

nesabitljiva, bit će i prednji pomični zid 8 potisnut prema naprijed. U prednjoj komori 6 javit će se izvjestan natpritisak jer zrak ne može otići. irrepressible, the front movable wall 8 will also be pushed forward. A certain overpressure will occur in the front chamber 6 because the air cannot escape.

Kada prednji pomični zid 8 bude potisnut dovoljno da se nađe nasuprot preljevnog kanala 12, bit će uspostavljena veza za tekućine između prednje i stražnje komore. Daljnjim kretanjem u naprijed stražnjeg pomičnog ribara 9, tekućina će biti potisnuta u prednju komoru 6 kroz preljevni kanal 12. U ovom stupnju, ili fazi, prednji pomični zid 8 neće se pomicati. When the forward movable wall 8 is pushed sufficiently to be opposite the overflow channel 12, fluid communication between the anterior and posterior chambers will be established. With further forward movement of the rear movable fish 9, the liquid will be forced into the front chamber 6 through the overflow channel 12. At this stage, or stage, the front movable wall 8 will not move.

Kada sva tekućina bude potisnuta u prednji prostor, stražnji pomični zid 9 doći će u mehanički dodir s prednjim pomičnim zidom 8. Tekućina će otopiti suhi medikament 10 i oblikovati otopinu za ubrizgavanje spreman za upotrebu. Držač 18 sa priključenom iglom 17 navrće se poslije toga na prednje kućište 13, pri čemu je membrana 3 cilindrične ampule probijena stražnjim vrhom 21 igle, a natpritisak u prednjoj komori je ispušten. When all the liquid has been forced into the front space, the rear movable wall 9 will come into mechanical contact with the front movable wall 8. The liquid will dissolve the dry medicament 10 and form an injectable solution ready for use. The holder 18 with the attached needle 17 is then screwed onto the front housing 13, whereby the membrane 3 of the cylindrical ampoule is pierced by the rear tip 21 of the needle, and the excess pressure in the front chamber is released.

Daljnjim potiskivanjem upravljačkog dugmeta 16, radna šipka 23 se aktivira tako da se zidovi 8 i 9 pomiču dalje u naprijed i zrak u cilindričnoj ampuli će izaći kroz iglu 17. Uređaj je sada spreman za ubrizgavanje kao što je prikazano na slici 5. By further pushing the control button 16, the operating rod 23 is activated so that the walls 8 and 9 move further forward and the air in the cylindrical ampoule will exit through the needle 17. The device is now ready for injection as shown in Figure 5.

Kod pripremanja uređaja neophodno je držati okomito, sa iglom usmjerenom naviše, a spajanje navojem ne smije se vršiti suviše brzo. Na taj će se način tekućina mirno penjati kroz supstanciju i otapati je, pri čemu nema jakog miješanja. Ovakvo jako miješanje je nepogodno za mnoge osjetljive supstancije jer može utjecati nepovoljno na materiju. When preparing the device, it is necessary to hold it vertically, with the needle pointing upwards, and the threading must not be done too quickly. In this way, the liquid will calmly climb through the substance and dissolve it, while there is no strong mixing. Such strong mixing is not suitable for many sensitive substances because it can adversely affect the matter.

To je jedno preporučljivo izvođenje kod koga je dvokomorna cilindrična ampula 1 postavljena u prednje kućište 13 a kruti medikament je otopljen prije no što igla 21 probije membranu 3 ampule. Pošto se javlja natpritisak, tendencija pjenušanja i oblikovanja mjehura smanjena je kada su tekućina i kruti materijal pomiješani, što je manje štetno za medikament. Međutim, za medikamente koji nisu toliko osjetljivi, držač 18 igle sa iglom može se navrnuti na prednji dio 13 kućišta prije no što je cilindrična ampula umetnuta i oba kućišta se međusobno spojena vijcima. Stražnji vrh igle će zatim probiti membranu 3 prije no što su kruta supstancija i tekućina pomiješani pri čemu ne dolazi do natpritiska u komori za miješanje. This is one recommended embodiment where the two-chamber cylindrical ampoule 1 is placed in the front housing 13 and the solid medication is dissolved before the needle 21 pierces the membrane 3 of the ampoule. Since overpressure occurs, the tendency for foaming and blistering is reduced when the liquid and solid material are mixed, which is less harmful to the medication. However, for medications that are not so sensitive, the needle holder 18 with the needle can be screwed onto the front part 13 of the housing before the cylindrical ampoule is inserted and the two housings are screwed together. The rear tip of the needle will then pierce the membrane 3 before the solid and liquid are mixed without overpressurizing the mixing chamber.

Kada uređaj treba koristiti za davanje lijeka ubrizgavanjem, prvo se skine zaštitna kapa sa igle. Poslije toga se određuje željena doza pomoću upravljačkog dugmeta 16 i pritiskivanjem upravljačkog dugmeta doza se ispušta kroz iglu. Poslije toga se mogu davati sljedeće doze sve dok ima otopine za injekcije u cilindričnoj ampuli. Poslije svakog ispuštanja igla se obično zamjenjuje novom sterilnom iglom. Ovo se može lako učiniti odvrtanjem držača 18 s priključenom iglom sa prednjeg kraja uređaja za ubrizgavanje poslije čega se navrne novi držač s iglom. Istodobno će stražnji zašiljeni kraj igle probiti membranu i ostvariti vezu tekućine do unutrašnjosti ampule. When the device is to be used to administer medicine by injection, the protective cap is first removed from the needle. After that, the desired dose is determined using the control button 16 and by pressing the control button, the dose is released through the needle. After that, subsequent doses can be given as long as there is solution for injection in the cylindrical ampoule. After each discharge, the needle is usually replaced with a new sterile needle. This can be easily done by unscrewing the holder 18 with the attached needle from the front end of the injection device and then screwing on a new holder with the needle. At the same time, the rear pointed end of the needle will pierce the membrane and establish a fluid connection to the inside of the ampoule.

Varijanta izvođenja prikazana na slici 6 obuhvaća jedan držač u koji se može postaviti kontejner 1. Držač se sastoji od dva cjevasta elementa koji se mogu spojiti navojem, i to prednjeg cjevastog elementa 24 i stražnjeg cjevastog elementa 28. Prednji cjevasti element 24 ima suženje 25 u svom prednjem kraju u koje se može postaviti prirubnica 2 grla ampule 1. Na svom stražnjem dijelu prednji cjevasti element je izveden s unutarnjim navojem 28 u koji se može zavrnuti vanjski navoj 27 na stražnjem cjevastom elementu 28. Kod svog stražnjeg kraja stražnji cjevasti element 28 ima zatvoren stražnji zid 29 za koji je pričvršćen sa unutarnje strane pričvršćen jedan nepokretan klip u stražnjem cjevastom elementu 28, pri čemu taj klip ima promjer manji od unutarnjeg promjera ampule i pruža se prema ampuli 1. The embodiment shown in Figure 6 includes one holder in which the container 1 can be placed. The holder consists of two tubular elements that can be connected by threading, namely the front tubular element 24 and the rear tubular element 28. The front tubular element 24 has a narrowing 25 in at its front end, in which the flange 2 of the ampoule neck 1 can be placed. At its rear part, the front tubular element is designed with an internal thread 28 into which the external thread 27 on the rear tubular element 28 can be screwed. At its rear end, the rear tubular element 28 has closed back wall 29, to which is attached from the inside a stationary piston in the rear tubular element 28, wherein this piston has a diameter smaller than the internal diameter of the ampoule and extends towards the ampoule 1.

Kod pripreme otopine za ubrizgavanje, stražnji cjevasti element 28 se zavrne u prednji cjevasti element 24, pri čemu je preporučljivo da se držač drži okomito tako da je suženo grlo 25 okrenuto naviše. Kada se zadnji cjevasti element 28 zavrne u prednji cjevasti element 24, nepokretni klip 30 pomaknut će stražnji cjevasti zid naviše i sabijati tekućinu 11 u stražnjem prostoru 7. Tekućina će proizvoditi pritisak na prednji zid 8 tako da će se ovaj pomicati naviše do položaja točno nasuprot spojnog kanala 12, u kojem položaju tekućina 11 može mirno protjecati kroz spojni kanal 12 u prednji prostor 6 i miješati se s medikamentom 10. Dok se dva cjevasta elementa 24 i 28 zavrću jedan u drugi, vrši se vrlo mirno protjecanje tekućine u prednji prostor 6, koji je pri tome zatvoren membranom na prednjem kraju ampule. Kada tekućina utječe u prednji prostor 8, u njemu se javlja pritisak viši od atmosferskog, tako da se u gornjem kraju ampule oblikuje jedan mali džep 31 sabijenog plina, što je prikazano na slici 7, koja prikazuje držač u položaju kada su cjevasti elementi 24 i 28 potpuno zavrnuti jedan u drugi, a sva tekućina se prelila u prednji prostor 6. Zahvaljujući mirnom dotjecanju tekućine u gornji prostor 6 oblikovanom pritisku višem od atmosferskog, spriječeno je oblikovanje pjene kod miješanja. Naravno, uređaj se može poslije toga nekoliko puta okrenuti, ako je potrebno, da bi se medikament potpuno otopio u tekućini. When preparing the solution for injection, the rear tubular element 28 is screwed into the front tubular element 24, whereby it is advisable to hold the holder vertically with the tapered neck 25 facing upwards. When the rear tubular element 28 is screwed into the front tubular element 24, the stationary piston 30 will move the rear tubular wall upwards and compress the fluid 11 in the rear space 7. The fluid will exert pressure on the front wall 8 so that the latter will move upwards to a position directly opposite of the connecting channel 12, in which position the liquid 11 can flow calmly through the connecting channel 12 into the front space 6 and mix with the medication 10. While the two tubular elements 24 and 28 are screwed into each other, a very quiet flow of liquid into the front space 6 takes place , which is closed by a membrane at the front end of the ampoule. When the liquid flows into the front space 8, a pressure higher than atmospheric occurs in it, so that a small pocket 31 of compressed gas is formed in the upper end of the ampoule, which is shown in Figure 7, which shows the holder in the position when the tubular elements 24 and 28 are completely twisted into each other, and all the liquid has overflowed into the front space 6. Thanks to the smooth flow of liquid into the upper space 6 at a pressure higher than atmospheric, the formation of foam during mixing is prevented. Of course, the device can be turned several times afterwards, if necessary, to completely dissolve the medication in the liquid.

Kada se ispušta otopina za ubrizgavanje pripremljena na ovaj način, uređaj se okrene u položaj prikazan na slici 8, pri čemu je prednji dio ampule 1 okrenut naniže, tako da se plin u prednjem prostoru 6 ampule 1 sakuplja kod gornjeg dijela a ne u blizini membrane. Otopina za ubrizgavanje se može uzimati pomoću cjevčice, kanule 32 koja se uvodi kroz membranu i prenosi do uobičajene brizgalice 33 za potkožno ubrizgavanje na poznati način. Lakše se izvlači otopina za ubrizgavanje iz ampule 1 zahvaljujući pritisku višem od atmosferskog koji djeluje u prednjem prostoru 6 ampule, tako da će otopina barem u početnom trenutku protjecati pod vlastitim pritiskom kroz cjevčicu, kanulu 32 u brizgalicu 33 za davanje potkožnih injekcija. When the injection solution prepared in this way is discharged, the device is turned to the position shown in Figure 8, with the front part of the ampoule 1 facing downwards, so that the gas in the front space 6 of the ampoule 1 is collected at the upper part and not near the membrane . The solution for injection can be taken by means of a tube, a cannula 32 which is introduced through the membrane and transferred to a conventional syringe 33 for subcutaneous injection in a known manner. It is easier to extract the injection solution from the ampoule 1 thanks to the higher than atmospheric pressure acting in the front space 6 of the ampoule, so that the solution will flow under its own pressure at least initially through the tube, the cannula 32 into the syringe 33 for giving subcutaneous injections.

Kao što je ranije rečeno, druga varijanta izvođenja uređaja prema izumu prikazana je na slikama 9 do 11, pri čemu ima iste komponente kao i uređaj prikazan na slikama 6 i 7. Glavna razlika je u tome, što je uređaj prema slikama 9 do 11 projektiran da bude neposredno povezan s jednom kanulom, cjevčicom, kod suženog grla 25 prednjeg prstenastog elementa 24. Pored toga, stražnji zid 29 prednjeg cjevastog elementa 28 nije zatvoren već ima jedan središnji otvor 34 kroz koji prolazi radna šipka 35. Radna šipka 35 je integralno povezana s klipom 30 u zadnjem cjevastom elementu, pri čemu klip nije povezan sa zadnjim cjevastim elementom 28 već je ograničeno pomičan u uzdužnom pravcu pomoću radne poluge 35. Kao i kod uređaja prikazanog na slikama 6 do 8, vanjski promjer klipa 30 je manji od unutarnjeg promjera ampule 1, ali je istodobno veći od promjera otvora 34 u stražnjem zidu 29, tako da se klip 30 ne može izvući iz stražnjeg cjevastog elementa 28. Dva cjevasta elementa 24 i 28 zavrću se jedan u drugi iz položaja prikazanog na slici 9, u kome su komponente otopine za ubrizgavanje potpuno razdvojene jedna od druge, na isti način kako je opisan u vezi sa prvom varijantom izvođenja prema slikama 6 do 8, dok se ne postigne potpuno miješanje i uređaj bude u položaju prikazanom na slici 10. U tom položaju se stavlja poklopac 36 na suženo grlo 25 prednjeg cjevastog elementa 24. Pored toga, kanula, cjevčica 32 je pričvršćena na poklopac 35, pri čemu probija membranu ampule 1 kada se poklopac stavlja na suženo grlo 25. To se vrši u okomitom položaju kada je grlo 25 okrenuto naviše. Uređaj je spreman za korištenje kao brizgalica za davanje injekcija, pri čemu se to vrši pritiskom na radnu šipku 35 tako da klip 30 pomiče dva pomična zida 8 i 9 u naprijed u prednji prostor 6 u ampuli, tako da se prvo iz ampule uklanja plin, zatim se otopina za ubrizgavanje ispušta kroz kanulu 32 na poznati način. As mentioned earlier, the second embodiment of the device according to the invention is shown in figures 9 to 11, where it has the same components as the device shown in figures 6 and 7. The main difference is that the device according to figures 9 to 11 is designed to be directly connected to one cannula, a tube, at the narrowed neck 25 of the front ring element 24. In addition, the rear wall 29 of the front tubular element 28 is not closed but has one central opening 34 through which the working rod 35 passes. The working rod 35 is integrally connected with the piston 30 in the last tubular element, wherein the piston is not connected to the last tubular element 28 but is limitedly movable in the longitudinal direction by means of the operating lever 35. As with the device shown in Figures 6 to 8, the outer diameter of the piston 30 is smaller than the inner diameter ampoule 1, but at the same time is larger than the diameter of the opening 34 in the rear wall 29, so that the piston 30 cannot be pulled out of the rear tubular element 28. The two tubular elements 24 and 28 are screwed together and into the other from the position shown in Figure 9, in which the components of the injection solution are completely separated from each other, in the same way as described in connection with the first embodiment according to Figures 6 to 8, until complete mixing is achieved and the device is in the position shown in Figure 10. In this position, the cover 36 is placed on the narrowed neck 25 of the front tubular element 24. In addition, the cannula, the tube 32 is attached to the cover 35, thereby piercing the membrane of the ampoule 1 when the cover is placed on the narrowed neck 25 This is done in a vertical position when the throat 25 is facing upwards. The device is ready to be used as a syringe for giving injections, whereby this is done by pressing the operating rod 35 so that the piston 30 moves the two movable walls 8 and 9 forward into the front space 6 in the ampoule, so that the gas is first removed from the ampoule, then the injection solution is discharged through the cannula 32 in a known manner.

Jedan vrlo praktičan i jednostavan instrument za pripremanje otopine za ubrizgavanje dobiva se uređajem prema izumu. Kao što je naprijed rečeno, uređaj osigurava vrlo mirno i sigurno miješanje komponenata otopine za ubrizgavanje. Ako se miješanje vrši suviše brzo, rezultat je oblikovanje čestica i opalescencija. Oba su izraz sakupljanja u grudve. Preporučljivo je da se uređaj izradi od plastične mase i u tom slučaju će cijena uređaja biti vrlo mala, pa se uređaj može koristiti jednokratno. Korka navoja na elementima nije kritičan, ali je preporučljivo da bude u granicama od 0,5 do 10 mm. One very practical and simple instrument for preparing a solution for injection is obtained with a device according to the invention. As mentioned above, the device ensures a very calm and safe mixing of the components of the injection solution. If mixing is done too quickly, the result is particle formation and opalescence. Both are expressions of gathering into lumps. It is recommended that the device be made of plastic, and in that case the price of the device will be very low, so the device can be used once. The pitch of the threads on the elements is not critical, but it is recommended that it be within the limits of 0.5 to 10 mm.

Najpogodnije je da se uređaj prema izumu koristi za potkožne injekcije, ali su i drugi postupci za davanje injekcije prema tekućoj medicinskoj praksi mogući, kao na primjer, intramuskularna injekcija. It is most convenient for the device according to the invention to be used for subcutaneous injections, but other procedures for administering the injection according to current medical practice are also possible, such as, for example, intramuscular injection.

Kada se cilindrična ampula isprazni, uređaj za ubrizgavanje se odvrtanjem rastavi i izvadi se prazna kapsula. Mehanizam za doziranje se postavi na nulu i poslije toga se uređaj ponovo može spremiti za ubrizgavanje, kao što je naprijed rečeno. Korisnik može lako nositi sa sobom sklopljen i pripremljen uređaj da bi ga koristio u pogodnim trenucima. When the cylindrical ampoule is empty, the injection device is disassembled by unscrewing and the empty capsule is removed. The dosing mechanism is set to zero and after that the device can be prepared for injection again, as mentioned above. The user can easily carry the assembled and prepared device with him to use it at convenient times.

Može biti neophodno da se zaštite osjetljivi medikamenti, naročito tipa polipeptida, protiv mehaničkog djelovanja kada su u otopljenom obliku. Posebno kritični momenti su pretvaranje osušenog praška u otopinu, s jedne strane, a s druge strane, daljnje rukovanje pripremljenom otopinom. Ovo drugo će biti posebno važno kada se radi o preparatima za veći broj doza kojima se mora rukovati više puta. It may be necessary to protect sensitive medications, especially of the polypeptide type, against mechanical action when in dissolved form. Especially critical moments are turning the dried powder into a solution, on the one hand, and on the other hand, further handling of the prepared solution. The latter will be especially important when dealing with preparations for a larger number of doses that must be handled several times.

Korištenje konvencionalnih pakiranja i brizgalica ne doprinosi zaštiti od mehaničkih naprezanja što, međutim, daje ovaj izum. Uspostavljanje otopine iz suhog praha pomoću izuma vrši se na vrlo pažljiv način određen konstrukcijom, tako da je medikament pošteđen. Kako se otopina priprema u izvjesnom natpritisku, u ovoj fazi je spriječeno pjenušanje i oblikovanje mjehurića. Daljnje rukovanje pripremljenom otopinom će također biti vrlo nježno prema izumu. Praktično je uklonjen sav zrak koji je bio u dodiru s otopinom kada se uređaj za ubrizgavanje priprema dati prvu injekciju iz novo postavljene dvokomorne cilindrične ampule. Na taj način je izbjegnuta međufaza koja kod rukovanja kontejnerom s otopinom dovodi do negativnih utjecaja na osjetljivi medikament, pa se poslije toga može rukovati kontejnerom bez posebnog vođenja računa o osjetljivosti otopine. The use of conventional packaging and syringes does not contribute to the protection against mechanical stress, which, however, this invention provides. The establishment of a solution from a dry powder using the invention is done in a very careful way determined by the construction, so that the medication is spared. As the solution is prepared under a certain overpressure, foaming and formation of bubbles is prevented at this stage. Further handling of the prepared solution will also be very gentle according to the invention. Virtually all the air that was in contact with the solution is removed when the injection device is prepared to give the first injection from the newly installed two-chamber cylindrical ampoule. In this way, the intermediate phase that leads to negative effects on the sensitive medication when handling the container with the solution is avoided, so after that the container can be handled without taking special account of the sensitivity of the solution.

Zbog toga je moguće da se prikazanim izumom pripremi jedna otopina koja se može koristiti duže ili kraće vrijeme na blagi način, i da se transportira pripremljena otopina bez snižavanja kvalitete osjetljivog medikamenta uslijed mehaničkog naprezanja. Zbog toga izum omogućava da i osjetljivi medikamenti mogu biti na raspolaganju za komforno ambulatno liječenje. For this reason, it is possible to prepare a single solution that can be used for a longer or shorter time in a gentle way, and to transport the prepared solution without lowering the quality of the sensitive medication due to mechanical stress. This is why the invention enables even sensitive medications to be available for comfortable outpatient treatment.

Medikamenti koji se mogu koristiti u prikazanom uređaju mogu se sastojati od bilo koje supstancije ili mješavina supstancija koje se koriste kod do sada poznatih dvokomornih ampula, ili su pogodne za ovu svrhu. Međutim, osjetljive materije koje ne mogu biti uskladištene duže vremena u otopini i koje imaju tendenciju mijenjanja kada se otope posebno su pogodne. Primjeri takvih supstancija su razni polipeptidi kao što su hormoni i interferon. Utvrđeno je da je izum posebno pogodan kod priprema i ubrizgavanja otopine hormona rasta. Oni su vrlo osjetljivi i lako se modificiraju kada se od njih priprema otopina. Korištenjem u ovom slučaju prikazanog izuma, takav je utjecaj znatno smanjen. To je krajnje neočekivano i stručnjaci ga nisu mogli predvidjeti. Medicaments that can be used in the device shown can consist of any substance or mixture of substances that are used in two-chamber ampoules known up to now, or are suitable for this purpose. However, sensitive materials that cannot be stored for long periods of time in solution and that tend to change when dissolved are particularly suitable. Examples of such substances are various polypeptides such as hormones and interferon. It has been found that the invention is particularly suitable for the preparation and injection of growth hormone solutions. They are very sensitive and easily modified when a solution is prepared from them. By using the invention presented in this case, such an impact is significantly reduced. This is extremely unexpected and the experts could not have predicted it.

Suhi medikamenti se obično nalaze u zamrzavanjem, sušenom ili liofiliziranom stanju prije pripreme otopine za ubrizgavanje od vode kojoj se često dodaju agensi za prilagođavanje osmotskog pritiska, konzervansi i sl., a u skladu s tekućom farmakološkom praksom. Također je moguće da sama tekuća faza može sadržavati otopljene supstancije koje mogu imati neko farmakološko djelovanje koje se potom može koristiti zajedno s djelovanjem agensa koji je kasnije otopljen u tekućini. Dry medications are usually in a freeze-dried or lyophilized state before preparation of a solution for injection from water to which agents for adjusting osmotic pressure, preservatives, etc. are often added, in accordance with current pharmacological practice. It is also possible that the liquid phase itself may contain dissolved substances that may have some pharmacological action that can then be used together with the action of an agent that is later dissolved in the liquid.

Drugo je izvođenje kod kojeg se tekućina može sastojati od emulzije masti koja se može ubrizgavati, kao što je ona koja je opisana u američkim patentnim spisima br. 4 073 943 i 4 168 308. U ovom slučaju suha supstancija za ubrizgavanje sadrži jedan u vodi topiv ili hidrofilni agens koji se otapa ili dispergira u vodenoj fazi emulzije u mješavini. Another embodiment is where the liquid may consist of an injectable fat emulsion, such as that described in US Pat. 4 073 943 and 4 168 308. In this case, the dry substance for injection contains a water-soluble or hydrophilic agent that dissolves or disperses in the aqueous phase of the emulsion in the mixture.

Uređaj za ubrizgavanje je načinjen od nekog pogodnog elementa kao što je metal, na primjer nehrđajući čelik ili legura aluminija ili neki pogodan plastični materijal. Izbor metala je potpuno u djelokrugu rada stručnjaka. The injection device is made of some suitable element such as metal, for example stainless steel or aluminum alloy or some suitable plastic material. The choice of metal is completely within the scope of work of experts.

Osim toga, potrebno je napomenuti da su postupak i uređaj prema izumu prikazani na crtežima i detaljno opisani samo primjeri, i da su moguća druga izvođenja također moguća u okviru patentnih zahtjeva. In addition, it should be noted that the method and device according to the invention are shown in the drawings and described in detail only as examples, and that other embodiments are also possible within the scope of the patent claims.

Claims (4)

1. Uređaj za ubrizgavanje injekcija, za pripremu otopina supstancija osjetljivih na degradaciju i za ubrizgavanje ove otopine, naznačen time, što sadrži a) kontejner (1) za komponente otopine za ubrizgavanje, u kome se komponente drže razdvojene ali se mogu sastaviti vanjskim djelovanjem da bi se miješale i otopile, a koji je načinjen kao cijev (1) koja je hermetički zatvorena na njenom prednjem dijelu pomoću membrane (3) koja se može probiti, kod koje se u prostoru (6) između membrane koja se može probiti i prednjeg pomičnog zida (8) nalaze krute komponente (10) otopine za ubrizgavanje, dok se u prostoru (7) između prednjeg pomičnog zida (8) i stražnjeg pomičnog zida (9) nalazi tekuća komponenta (11) otopine za ubrizgavanje, i što je u cjevastom zidu izveden spojni kanal (12) tako postavljenim da kada se stražnji pomični zid (9) pomiče u naprijed zajedno s tekućinom (11) i prednjim pomičnim zidom (8), a tekućina može teći pored prednjeg pomičnog zida (8) i pomiješati se s krutim komponentama (10) do dobivanja otopine; b) držač u kome se kontejner (1) može tako učvrstiti da se komponente otopine za ubrizgavanje mogu dovesti u dodir i miješati, a koji je načinjen od dva cjevasta elementa (13, 14) koji se mogu zavrnuti jedan u drugi i obuhvaćaju kontejner (1) tako da kada se elementi spoje navojem prednji je dio kontejnera s membranom (3) koja se može probiti izložen kod prednjeg kraja držača kako bi ga probila igla (17, 21) za injekcije, i što je kod stražnjeg kraja stražnji pomični zid (9) pomaknut u naprijed zajedno s tekućinom (11) i prednjim pomičnim zidom (8) tako da se tekućina (11) prinudi da teče kroz spojni kanal (12) do prostora (6) s krutim komponentama da bi se sa istima miješala i oblikovala otopinu; c) držač (18) za iglu (17) za injekcije pripremljen za postavljanje na prednji dio držača (13) kontejnera tako da se igla (21) može povezati s prostorom (6) kontejnera kroz membranu (3) koja se može probiti; i d) naprava (22) za doziranje s držačem (14) kontejnera, čijim se djelovanjem primorava pomični zid (9) u kontejneru da se pomiče prema naprijed na kontrolirani način, izdajući pri tome određene doze otopine za brizganje, pri čemu se naprava (22) za doziranje postaviujedan početni položaj radi doziranja kada se vijcima pričvrsti za držače (13, 14) kontejnera.1. Device for injecting injections, for preparing solutions of substances sensitive to degradation and for injecting this solution, indicated by the fact that it contains a) a container (1) for the components of the injection solution, in which the components are kept separate but can be brought together by external action to mix and dissolve, and which is made as a tube (1) that is hermetically sealed at its front by means of a membrane (3) which can be penetrated, where in the space (6) between the membrane which can be penetrated and the front movable wall (8) there are solid components (10) of the injection solution, while in the space (7) between the front movable wall (8) and the rear movable wall (9) contains the liquid component (11) of the injection solution, and that in the tubular wall there is a connection channel (12) positioned so that when the rear movable wall (9) moves forward together with the liquid ( 11) and the front movable wall (8), and the liquid can flow past the front movable wall (8) and mix with the solid components (10) until a solution is obtained; b) a holder in which the container (1) can be fixed in such a way that the components of the injection solution can be brought into contact and mixed, which is made of two tubular elements (13, 14) that can be screwed into each other and enclose the container ( 1) so that when the elements are threaded together the front part of the container with the membrane (3) that can be pierced is exposed at the front end of the holder to be pierced by the needle (17, 21) for injections, and that at the rear end is the rear movable wall ( 9) moved forward together with the liquid (11) and the front movable wall (8) so that the liquid (11) is forced to flow through the connecting channel (12) to the space (6) with the solid components to mix and shape them solution; c) a holder (18) for a needle (17) for injections prepared to be placed on the front part of the holder (13) of the container so that the needle (21) can be connected to the space (6) of the container through a membrane (3) that can be pierced; and d) a dosing device (22) with a holder (14) of the container, the action of which forces the movable wall (9) in the container to move forward in a controlled manner, thereby issuing certain doses of the injection solution, whereby the device (22 ) for dosing, set a starting position for dosing when it is attached to the holders (13, 14) of the container with screws. 2. Uređaj za ubrizgavanje injekcija, za pripremanje otopine za ubrizgavanje medikamenata od supstancija osjetljivih na razlaganje, naznačen time, što se komponente otopine za ubrizgavanje čuvaju u kontejneru (1) u kome su komponente razdvojene, ali se mogu sakupiti da bi se miješale i otopile vanjskim utjecajem i koja je načinjena kao cijev koja je hermetički zatvorena na svom prednjem kraju (2) pomoću jedne membrane koja se može probiti, koja sadrži prostor (6) između zida koji se može probiti i jednog prednjeg pomičnog zida (8) u kome se nalaze krute komponente (10) otopine za ubrizgavanje, dok u prostoru (7) između prednjeg pomičnog zida (8) i stražnjeg pomičnog zida (9) nalaze se tekuće komponente otopine za ubrizgavanje, i koji ima u cjevastom zidu jedan spojni kanal (12) tako postavljen da, kada se stražnji pomični zid (9) pomakne prema naprijed zajedno s tekućinom (11) i prednjim pomičnim zidom (8), tekućina (11) može teći pored prednjeg pomičnog zida (8) i miješati se s krutim komponentama (10) do dobivanja otopine, i što uređaj obuhvaća jedan držač (24,28) u kojem se kontejner može učvrstiti tako da se komponente (10, 11) otopine za ubrizgavanje mogu dovesti u dodir i miješati, i koji je načinjen od dva cjevasta elementa (24, 28) koji se mogu zavrnuti jedan u drugi, pri čemu je prednji dio (2) kontejnera (1) s membranom koja se može probiti izlizan kod prednjeg dijela (25) držača, i što se kod stražnjeg dijela kontejnera (1) stražnji cjevasti zid (9) pomiče prema naprijed zajedno s tekućinom (11) i prednjim pomičnim zidom (8) pomoću klipa (30) postavljenog kod stražnjeg dijela (28) držača koji potiskuje stražnji pomični zid (9) posude, kontejnera (1) tako da se tekućina (11) može dovesti da teče kroz spojni kanal (12) u prostor (6) krutih komponenata (10) i miješati se sa istima do dobivanja neke otopine.2. Device for injecting injections, for preparing a solution for injection of medication from substances sensitive to decomposition, characterized in that the components of the solution for injection are kept in a container (1) in which the components are separated, but can be collected to mix and dissolve by external influence and which is made as a tube that is hermetically sealed at its front end (2) by means of a breakable membrane, which contains a space (6) between a breakable wall and a front movable wall (8) in which there are solid components (10) of the injection solution, while in the space (7) between the front movable wall (8) and the rear movable wall (9) there are liquid components of the injection solution, and which has a connecting channel (12) in the tubular wall arranged so that, when the rear movable wall (9) moves forward together with the liquid (11) and the front movable wall (8), the liquid (11) can flow past the front movable wall (8) and mix with the solid components (10) to obtain a solution, and that the device comprises a holder (24, 28) in which the container can be fixed so that the components (10, 11) of the injection solution can be brought into contact and mixed, and which is made of two tubular elements (24, 28) that can be screwed into each other, whereby the front part (2) of the container (1) with a membrane that can be pierced is worn at the front part (25) of the holder, and what is at the rear part of the container ( 1) the rear tubular wall (9) moves forward together with the liquid (11) and the front movable wall (8) by means of a piston (30) placed at the rear part (28) of the holder which pushes the rear movable wall (9) of the vessel, container (1) ) so that the liquid (11) can be made to flow through the connecting channel (12) into the space (6) of the solid components (10) and mix with them until a solution is obtained. 3. Uređaj prema zahtjevu 2, naznačen time, što je klip (30) nepokretno postavljen kod stražnjeg dijela (28) držača i što je prednji dio (24) držača izveden s jednim otvorom neposredno ispred membrane koja se može probiti u kontejneru, tako da se jedna cjevčica, kanula može umetnuti kroz otvor i membranu koja se može kidati radi izvlačenja pripremljene otopine za ubrizgavanje za brizgalicu (33) za davanje injekcija.3. The device according to claim 2, characterized in that the piston (30) is immovably placed at the rear part (28) of the holder and that the front part (24) of the holder is designed with one opening directly in front of the membrane that can be pierced in the container, so that is one tube, the cannula can be inserted through the opening and the tearable membrane to withdraw the prepared injection solution for the syringe (33) for giving the injections. 4. Uređaj prema zahtjevu 2, naznačen time, što je klip (30) izveden s radnom šipkom (35) koja se pruža kroz stražnji zid (29) kod stražnjeg dijela (28) držača, i što je jedan priključak na jednu kanulu (32) postavljen kod prednjeg dijela (25) držača koji se može prilagoditi držačima (24, 25) a zatim probija membranu kontejnera (1).4. Device according to claim 2, characterized in that the piston (30) is made with a working rod (35) that extends through the rear wall (29) at the rear part (28) of the holder, and that one connection to one cannula (32 ) placed at the front part (25) of the holder which can be adapted to the holders (24, 25) and then pierces the membrane of the container (1).
HRP-1284/88A 1987-07-02 1992-10-02 A device for injection HRP920949B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE8702735A SE465065B (en) 1987-07-02 1987-07-02 Method and device for preparing and injecting an injection solution
SE8801405A SE464797B (en) 1988-04-15 1988-04-15 Device for preparing an injection solution
YU128488A YU46917B (en) 1987-07-02 1988-07-01 PROCEDURE AND DEVICE FOR PREPARATION AND INJECTION OF INJECTION AQUEOUS SOLUTION OF EMULSION OR SUSPENSION

Publications (2)

Publication Number Publication Date
HRP920949A2 true HRP920949A2 (en) 1994-10-31
HRP920949B1 HRP920949B1 (en) 1997-12-31

Family

ID=27355398

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP-1284/88A HRP920949B1 (en) 1987-07-02 1992-10-02 A device for injection

Country Status (2)

Country Link
HR (1) HRP920949B1 (en)
SI (1) SI8811284A (en)

Also Published As

Publication number Publication date
SI8811284A (en) 1997-06-30
HRP920949B1 (en) 1997-12-31

Similar Documents

Publication Publication Date Title
US4968299A (en) Method and device for injection
US4515586A (en) Powder syringe mixing system
US7713244B1 (en) Syringes for administering pasty or semi-solid formulations
EP1094857B1 (en) A medical delivery device and a cartridge assembly for use in the same
US8523807B2 (en) Airless mixing with a by-pass syringe
US9867948B2 (en) Administering device with priming function
EP2296797B1 (en) Rack and pinion drive for by-pass cartridge
EP2432528B1 (en) Steroid delivery system
CZ20023823A3 (en) Medicinal assembly
KR102603583B1 (en) mixing vial
US8998880B2 (en) Airless mixing with a by-pass syringe
US9375385B2 (en) Pre-filled active vial having integral plunger assembly
JPH0531191A (en) Injector filled with immediate solution type medicine
US9833572B2 (en) Modular dual chamber syringe system
CN109890440B (en) Syringe-connector device for separately administering at least two products in controlled amounts in one injection
HRP920949A2 (en) Method and device for injection
US3498295A (en) Cartridge for use in multiple injection device
WO2011114344A1 (en) Multi dose cartridge for homogeneous liquid medicament solution
JPH0130500B2 (en)
SE465065B (en) Method and device for preparing and injecting an injection solution

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: KABI PHARMACIA AKTIEBOLAG, SE

B1PR Patent granted
PNAN Change of the applicant name, address/residence

Owner name: PHARMACIA & UPJOHN AKTIEBOLAG, SE

Owner name: PHARMACIA AKTIEBOLAG, SE

ODRP Renewal fee for the maintenance of a patent

Payment date: 20070628

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20080702